Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis

SC Li - Pediatric Clinics, 2018 - pediatric.theclinics.com
Scleroderma comes from the Greek word for “hard skin” and refers to diseases associated
with excessive production of collagen resulting in fibrosis of skin and other affected organs …

Morphea: the 2023 update

C Papara, DA De Luca, K Bieber, A Vorobyev… - Frontiers in …, 2023 - frontiersin.org
Morphea, also known as localized scleroderma, is a chronic inflammatory connective tissue
disorder with variable clinical presentations, that affects both adults and children. It is …

Immunopathogenesis of pediatric localized scleroderma

KS Torok, SC Li, HM Jacobe, SF Taber… - Frontiers in …, 2019 - frontiersin.org
Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation
and fibrosis of the skin that, especially in the pediatric population, also affects …

Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric‐or adult‐onset disease

JS Mertens, MMB Seyger, W Kievit… - British Journal of …, 2015 - academic.oup.com
Summary Background Localized scleroderma (LoS) is characterized by a phase of disease
activity followed by remission. However, disease recurrences occur. Knowledge concerning …

Disease course and long-term outcome of juvenile localized scleroderma: experience from a single pediatric rheumatology centre and literature review

G Martini, G Fadanelli, A Agazzi, F Vittadello… - Autoimmunity …, 2018 - Elsevier
Abstract Juvenile Localized Scleroderma (JLS) is a rare disorder that may cause severe
aesthetic sequelae and functional disability. To date, data on natural history and long-term …

Application of an iPSC‐derived organoid model for localized scleroderma therapy

J Ma, W Li, R Cao, D Gao, Q Zhang, X Li, B Li… - Advanced …, 2022 - Wiley Online Library
Localized scleroderma (LoS) is a rare chronic disease with extensive tissue fibrosis,
inflammatory infiltration, microvascular alterations, and epidermal appendage lesions …

The molecular pathogenesis of morphoea: from genetics to future treatment targets

AM Saracino, CP Denton… - British Journal of …, 2017 - academic.oup.com
A number of immunoinflammatory and profibrotic mechanisms are recognized in the
pathogenesis of broad sclerotic skin processes and, more specifically, morphoea. However …

Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma

SC Li, GC Higgins, M Chen, KS Torok… - …, 2021 - academic.oup.com
Objective The aim of this study was to evaluate factors associated with extracutaneous
involvement (ECI) in juvenile localized scleroderma (jLS). Methods A prospective …

Clinical characteristics and histopathologic changes of morphea: A single-center, retrospective study of 137 patients

J Kim, KB Chung, YI Lee, J Kim, JH Lee - Journal of the American Academy …, 2021 - Elsevier
Background The clinicopathologic correlations and prognostic risk factors for refractory
disease in morphea (localized scleroderma) are poorly described. Objective To investigate …

Changes in disease activity and damage over time in patients with morphea

JC O'Brien, H Nymeyer, A Green… - JAMA dermatology, 2020 - jamanetwork.com
Importance Prospective studies of the disease course in patients with morphea are lacking,
particularly those comparing adults and children. Objective To investigate the disease …